[Podcast] Company Culture, Core Values, and Global Growth | Episode 14 | BioAgilytix

On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President & CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors came into play when finalizing the acquisitions. The two biotech companies acquired, MicroConstants in San Diego, California, and 360biolabs in Melbourne and Brisbane Australia, are leaders in bioanalysis, and both are aligned with the BioAgilytix core values: Integrity, Customer Experience, Accountability, Respect, and Employee Experience.  

They also discuss BioAgilytix’s new London-based investor Cinven, which will create the opportunity to grow BioAgiliytix through additional acquisitions, building additional campuses, ensuring state-of-the-art equipment at all locations, and the opportunity for professional development. 

About BioAgilytix

See what makes BioAgilytix a different kind of bioanalytical contract research organization... and the choice for pharmaceutical and biotechnology companies looking for an expert, science-driven partner to advance their complex large molecule studies.

Facebook:   / bioagilytix  
Twitter:   / bioagilytix  
LinkedIn:   / 249673  

Site: https://www.bioagilytix.com/

#BioAgilytix #MolecularMoments